OUTCOMES FOR BREAST CANCER
5-Year Survival Rate for Breast Cancer Patients (updated Nov 2012)
DeKalb Surgical Associates has implemented a method of continuous outcomes assessment for a variety of clinical indicators. One of these indicators looks at the long-term survival of patients with breast cancer. Overall five year survival for our breast cancer patients is almost 84%. This seems like a fairly significant improvement over our five year survival rates from an earlier time frame, as shown below for patients diagnosed in 1997-98 when the overall survival was about 78%. These rates can vary a bit up and down from one time frame to another without necessarily being significant, but it is certainly encouraging, and the national data shows a similar higher overall survival rate, increasing from about 76% to about 85%.
This data has been compared to published data from the National Cancer Data Bank, and is shown below, and includes patients from 2003-05. For a more homogeneous comparison, the data is shown by individual stages. Our results are equivalent to national data. The slight differences in 5 year survival (higher for Stage III, and lower for Stage II) are not statistically significantly different from the national data. These differences can occur for a variety of reasons, including differences in the patient populations. Older outcomes comparison data is shown below in green font, for reference.
5-Year Survival Rate for Breast Cancer Patients (updated Feb 2012)
DeKalb Surgical Associates has implemented a method of continuous outcomes assessment for a variety of clinical indicators. One of these indicators looks at the long-term survival of patients with breast cancer. Overall five year survival for our breast cancer patients is almost 83%. This seem like a fairly significant improvement over our five year survival rates from an earlier time frame, as shown below for patients diagnosed in 1997-98 when the overall survival was about 78%. These rates can vary a bit up and down from one time frame to another without necessarily being significant, but it is certainly encouraging, and the national data shows a similar higher overall survival rate, increasing from about 76% to 85%
This data has been compared to published data from the National Cancer Data Bank, and is shown below, and includes patients from 2003-04. Our results are equivalent to national data.
Comparisons by stage 2 and 3 are shown separately below, and our rates are statistically the same as nationally reported survival rates.
These are results from older analyses, for comparison. the graph to the right shows overall survival as reported in 2005, for women diagnosed in 1997-98. Data for patients with Stage II breast cancer from 1997-98 shows similar results for this sub-group. This was the most recent data available at the time for looking at 5-year survival rates. The national data shown (NCDB, which stands for “National Cancer Data Base”) is from 1995-96. The other comparison was with all other Stage II breast cancer patients treated at DeKalb Medical Center during the 1997-98 time period. The 5-year survival for our patients was 87% compared with 80% for all other patients at DeKalb Medical Center.
